Risk of myocardial infarction in trials with Dipeptidyl Peptidase-4 inhibitors: Is duration of study a real issue?

被引：4
|
作者：
Dicembrini, Ilaria [1 ]
Mannucci, Edoardo [1 ]
机构：
[1] Careggi Teaching Hosp, Diabetol, Florence, Italy
来源：
INTERNATIONAL JOURNAL OF CARDIOLOGY | 2015年 / 184卷
关键词：
Type; 2; diabetes; Myocardial infarction; Dipeptidyl Peptidase 4 inhibitors; METAANALYSIS;
D O I：
10.1016/j.ijcard.2015.02.034
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：543 / 544
页数：2
相关论文
共 50 条
  • [1] Dipeptidyl peptidase-4 inhibitors increase risk of IBD
    Reactions Weekly, 2018, 1696 (1) : 5 - 5
  • [2] Dipeptidyl peptidase-4 inhibitors and osteoporosis
    Lee, Wen-Ling
    Lee, Fa-Kung
    Wang, Peng-Hui
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2022, 85 (09) : 889 - 890
  • [3] The role of dipeptidyl peptidase-4 inhibitors
    Lasserson, Daniel
    Mant, Jonathan
    BRITISH MEDICAL JOURNAL, 2012, 344
  • [4] DIPEPTIDYL PEPTIDASE-4 INHIBITORS, SULPHONYLUREAS, AND HYPOGLYCAEMIA Inclusion of the EXAMINE study in a meta-analysis of the addition of dipeptidyl peptidase-4 inhibitors to sulphonylureas and risk of hypoglycaemia
    Boucaud-Maitre, Denis
    BMJ-BRITISH MEDICAL JOURNAL, 2016, 353
  • [5] Dipeptidyl Peptidase-4 Inhibitors and Heart Failure Risk Analysis
    Vardarli, I.
    Ozcelik, C.
    KARDIOLOGE, 2014, 8 (06): : 448 - 450
  • [6] Gliptins (dipeptidyl peptidase-4 inhibitors) and risk of acute pancreatitis
    Scheen, Andre
    EXPERT OPINION ON DRUG SAFETY, 2013, 12 (04) : 545 - 557
  • [7] Dipeptidyl peptidase-4 inhibitors and risk of cancer: myth or reality?
    Monami, M.
    Dicembrini, I.
    Zannoni, S.
    Lamanna, C.
    Mannucci, E.
    DIABETOLOGIA, 2011, 54 : S310 - S310
  • [8] Dipeptidyl peptidase-4 inhibitors and cardiovascular risk: a meta-analysis of randomized clinical trials
    Monami, M.
    Ahren, B.
    Dicembrini, I.
    Mannucci, E.
    DIABETES OBESITY & METABOLISM, 2013, 15 (02): : 112 - 120
  • [9] Dipeptidyl peptidase-4 inhibitors and pancreatitis risk: a meta-analysis of randomized clinical trials
    Monami, M.
    Dicembrini, I.
    Mannucci, E.
    DIABETES OBESITY & METABOLISM, 2014, 16 (01): : 48 - 56
  • [10] Dipeptidyl peptidase-4 inhibitors versus sulfonylureas on the top of metformin in patients with diabetes and acute myocardial infarction
    Her, Ae-Young
    Choi, Byoung Geol
    Rha, Seung-Woon
    Kim, Yong Hoon
    Jeong, Myung Ho
    CARDIOVASCULAR DIAGNOSIS AND THERAPY, 2024, 14 (01) : 38 - 50
12345